INFLAMMATION AND BIOMARKERS
Centro de Investigación Cooperativa en Biotecnología
Zamudio, EspañaPublications in collaboration with researchers from Centro de Investigación Cooperativa en Biotecnología (10)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports, Vol. 43, Núm. 3
2022
-
Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals
Hepatology, Vol. 75, Núm. 3, pp. 550-566
-
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage
Nature Communications, Vol. 13, Núm. 1
2021
-
Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH
Journal of Hepatology, Vol. 75, Núm. 1, pp. 34-45
2020
-
Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease
Aging Cell, Vol. 19, Núm. 8
2019
-
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
EBioMedicine, Vol. 40, pp. 406-421
2012
-
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis
Genes and Immunity, Vol. 13, Núm. 1, pp. 21-28
2007
-
ITGA4 polymorphisms and susceptibility to multiple sclerosis
Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 151-157
2006
-
Celecoxib inhibits interleukin-12 αβ and β2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum
Molecular Pharmacology, Vol. 69, Núm. 5, pp. 1579-1587